Douglas P. Golwas - Chief Commercial Officer, 10%+ Owner at Medline Inc.

Issuer-level insider activity

Identity Names, identifiers, and filing context for this profile. 1 identity field
Entity type
Individual
Source evidence Original filing metadata and source links for verification. 1 source field
Source filing history
Open source filing history

Past-year transaction volume for Douglas P. Golwas in Medline Inc.

Buys

Open market
Shares
Avg price
Total value

Sells

Open market
Shares
-100,000
Avg price
$36.77
Total value
-$3,677,115

Net

Past year
Shares
-100,000
Share %
-100%
Total value
-$3,677,115

Reported holdings for Douglas P. Golwas in Medline Inc.

Form 4 holding Chief Commercial Officer, 10%+ Owner

Medline Inc.

Security class
Class B Common Stock
Shares / value
365,864
Estimated value
Report date
16 Jun 2026
Price
Ownership
Direct
Form 4 holding Chief Commercial Officer, 10%+ Owner

Medline Inc.

Security class
Common Units of Medline Holdings, LP
Shares / value
365,864
Estimated value
Report date
16 Jun 2026
Price
Ownership
Indirect
Underlying class
Class A Common Stock
Underlying amount
Form 4 holding Chief Commercial Officer, 10%+ Owner

Medline Inc.

Security class
Incentive Units of Medline Holdings, LP
Shares / value
149,005
Estimated value
Report date
16 Dec 2025
Price
Ownership
Indirect
Underlying class
Class A Common Stock
Underlying amount

Transaction history for Douglas P. Golwas in Medline Inc.

Sym Class Transaction % SEC-reported value SEC-reported price Shares Shares after Date Ownership
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .